{"entity":{"type":"insider","cik":"0001838573","url":"/insider/0001838573","json_url":"/insider/0001838573.json","name":"F2 Bioscience I 2017 Ltd","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":2,"first":"2021-01-14","last":"2022-06-23","span_basis":"filed_date"},"name_variants":[{"name":"F2 Bioscience I 2017 Ltd","source":"filing","n_filings":2,"first_seen":"2021-01-14","last_seen":"2022-06-23"}],"transactions":[{"id":6927765,"accession":"0001104659-22-073980","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-22-073980","line_url":"/filing/0001104659-22-073980#line-3","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"Cullinan Oncology, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"Jovan-Embiricos Morana; F2 Bioscience I 2017 Ltd","owner_display_name":"Jovan-Embiricos Morana","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29631.0,"shares_display":"29,631","price_per_share":13.0036,"price_display":"13.00","price_state":"stated","total_value":385309.6716,"total_display":"385,309.67","total_whole":"385,310","shares_owned_after":537392.0,"shares_owned_after_display":"537,392","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-23","filed_date":"2022-06-23","scope":"insider"},{"id":6927762,"accession":"0001104659-22-073980","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-22-073980","line_url":"/filing/0001104659-22-073980#line-2","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"Cullinan Oncology, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"Jovan-Embiricos Morana; F2 Bioscience I 2017 Ltd","owner_display_name":"Jovan-Embiricos Morana","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":49953.0,"shares_display":"49,953","price_per_share":12.7035,"price_display":"12.70","price_state":"stated","total_value":634577.9355,"total_display":"634,577.94","total_whole":"634,578","shares_owned_after":567023.0,"shares_owned_after_display":"567,023","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-22","filed_date":"2022-06-23","scope":"insider"},{"id":6927758,"accession":"0001104659-22-073980","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-073980","line_url":"/filing/0001104659-22-073980#line-1","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"Cullinan Oncology, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"Jovan-Embiricos Morana; F2 Bioscience I 2017 Ltd","owner_display_name":"Jovan-Embiricos Morana","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22319.0,"shares_display":"22,319","price_per_share":12.7662,"price_display":"12.77","price_state":"stated","total_value":284928.8178,"total_display":"284,928.82","total_whole":"284,929","shares_owned_after":616976.0,"shares_owned_after_display":"616,976","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-21","filed_date":"2022-06-23","scope":"insider"},{"id":4083654,"accession":"0000899243-21-002048","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0000899243-21-002048","line_url":"/filing/0000899243-21-002048","is_derivative":false,"issuer_cik":"0001575745","issuer_name":"Cullinan Management, Inc.","issuer_ticker":"CGEM","issuer_name_source":null,"issuer_url":"/issuer/0001575745","owner_cik":null,"owner_name":"F2 - TPO Investments LLC; Jovan-Embiricos Morana; F2 MG Ltd; Globeways Holdings Ltd; F2 Bioscience I 2017 Ltd; F2 MC, LLC; F2 Bio TD, LLC; F2 Vision SCS; F2 GC, LLC","owner_display_name":"F2 - TPO Investments LLC","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200000.0,"shares_display":"200,000","price_per_share":21.0,"price_display":"21.00","price_state":"stated","total_value":4200000.0,"total_display":"4,200,000.00","total_whole":"4,200,000","shares_owned_after":104762.0,"shares_owned_after_display":"104,762","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-01-12","filed_date":"2021-01-14","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001789972","name":"Cullinan Oncology, Inc.","url":"/issuer/0001789972","role":"Ten percent owner","n_filings":2,"first_seen":"2021-01-14","last_seen":"2022-06-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001838573","retrieved_at":"2026-08-27T10:45:01+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}